They analyze a new pathway for the treatment of Sézary syndrome

Blocking specific cellular signaling pathways may be an effective approach to treating this type of cutaneous lymphoma. One of its characteristics is its high genetic and molecular heterogeneity, which makes it difficult to find therapeutic targets. Now, a study published in the Journal of Investigative Dermatology may help to address this.

The Sézary syndrome is a rare and aggressive type of cutaneous T-cell lymphoma that affects the skin. One of its characteristics is its high genetic and molecular heterogeneity. This makes it difficult to identify therapeutic genetic targets to treat it

Read more sobre "They analyze a new pathway for the treatment of Sézary syndrome"